Aurinia Pharmaceuticals Inc. (AUPH)

Paramount Global Revenue

Aurinia Pharmaceuticals had revenue of $70.01M in the quarter ending June 30, 2025, with 22.41% growth. This brings the company's revenue in the last twelve months to $260.11M, up 25.59% year-over-year. In the year 2024, Aurinia Pharmaceuticals had annual revenue of $235.13M with 33.97% growth.

• Revenue (ttm): $260.11M
• Revenue Growth: +25.59%
• P/S Ratio: 6.11
• Revenue / Employee: $2,000,854
• Employees: 130
• Market Cap: 1.50B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	235.13M	59.62M	33.97%
Dec 31, 2023	175.51M	41.48M	30.95%
Dec 31, 2022	134.03M	88.43M	193.89%
Dec 31, 2021	45.61M	-4.51M	-9.00%
Dec 31, 2020	50.12M	49.80M	15,660.38%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.